Diabetes Patients at Risk From Rising Insulin Prices
A Yale study found that one in four patients admitted to cutting back on insulin use because of cost. The consequences can be deadly.
Source: NYT Health - Category: Consumer Health News Authors: RANDI HUTTER EPSTEIN, M.D. and RACHEL STRODEL Tags: Diabetes Insulin Health Insurance and Managed Care Drugs (Pharmaceuticals) Prices (Fares, Fees and Rates) Generic Brands and Products Source Type: news
More News: Diabetes | Endocrinology | Health | Health Insurance | Insulin | Insurance | Managed Care | Study | Yale